Results: 1-25 | 26-50 | 51-75 | 76-100 | >>
Results: 1-25/123

Authors: NEVITT MC ETTINGER B BLACK DM STONE K JAMAL SA ENSRUD K SEGAL M GENANT HK CUMMINGS SR
Citation: Mc. Nevitt et al., THE ASSOCIATION OF RADIOGRAPHICALLY DETECTED VERTEBRAL FRACTURES WITHBACK PAIN AND FUNCTION - A PROSPECTIVE-STUDY, Annals of internal medicine, 128(10), 1998, pp. 793

Authors: FERESHETIAN AG DAVIDSON M HABER H BLACK DM
Citation: Ag. Fereshetian et al., GEMFIBROZIL TREATMENT IN PATIENTS WITH ELEVATED LIPOPROTEIN A - A PILOT-STUDY, Clinical drug investigation, 16(1), 1998, pp. 1-7

Authors: KOREN MJ SMITH DG HUNNINGHAKE DB DAVIDSON MH MCKENNEY JM WEISS SR SCHROTT HG HENLEY RW TRESH P MCLAIN RW BAKKERARKEMA RG BLACK DM
Citation: Mj. Koren et al., THE COST OF REACHING NATIONAL-CHOLESTEROL-EDUCATION-PROGRAM (NCEP) GOALS IN HYPERCHOLESTEROLEMIC PATIENTS - A COMPARISON OF ATORVASTATIN, SIMVASTATIN, LOVASTATIN AND FLUVASTATIN, PharmacoEconomics, 14(1), 1998, pp. 59-70

Authors: HURLSTONE A BLACK DM
Citation: A. Hurlstone et Dm. Black, PROSTATE-CANCER - NEW THERAPIES IN THE PIPELINE, Current biology, 8(12), 1998, pp. 428-430

Authors: ZHAO JQ HOARE SF MCFARLANE R MUIR S PARKINSON EK BLACK DM KEITH WN
Citation: Jq. Zhao et al., CLONING AND CHARACTERIZATION OF HUMAN AND MOUSE TELOMERASE RNA GENE PROMOTER SEQUENCES, Oncogene, 16(10), 1998, pp. 1345-1350

Authors: BAKKERARKEMA RG BEST J FAYYAD R HEINONEN TM MARAIS AD NAWROCKI JW BLACK DM
Citation: Rg. Bakkerarkema et al., A BRIEF PAPER OF THE EFFICACY AND SAFETY OF ATORVASTATIN IN EARLY CLINICAL-TRIALS, Perfusion, 11(2), 1998, pp. 79-86

Authors: STONE K BAUER DC BLACK DM SKLARIN P ENSRUD KE CUMMINGS SR
Citation: K. Stone et al., HORMONAL PREDICTORS OF BONE LOSS IN ELDERLY WOMEN - A PROSPECTIVE-STUDY, Journal of bone and mineral research, 13(7), 1998, pp. 1167-1174

Authors: WOLFFENBUTTEL BHR MAHLA G MULLER D PENTRUP A BLACK DM
Citation: Bhr. Wolffenbuttel et al., EFFICACY AND SAFETY OF A NEW CHOLESTEROL-SYNTHESIS INHIBITOR, ATORVASTATIN, IN COMPARISON WITH SIMVASTATIN AND PRAVASTATIN, IN SUBJECTS WITH HYPERCHOLESTEROLEMIA, Netherlands journal of medicine, 52(4), 1998, pp. 131-137

Authors: BLACK DM BAKKERARKEMA R HEINONEN T NAWROCKI JW
Citation: Dm. Black et al., EFFICACY AND SAFETY OF ATORVASTATIN IN HYPERLIPIDEMIC PATIENTS WITH CONCURRENT HYPERTENSION OR NON-INSULIN-DEPENDENT DIABETES-MELLITUS, Journal of hypertension, 16, 1998, pp. 31018-31018

Authors: BLACK DM
Citation: Dm. Black, STATINS AND FIBRINOGEN, Lancet, 351(9113), 1998, pp. 1430-1430

Authors: HUNNINGHAKE D BAKKERARKEMA RG WIGAND JP DREHOBL M SCHROTT H EARLY JL ABDALLAH P MCBRIDE S BLACK DM
Citation: D. Hunninghake et al., TREATING TO MEET NCEP-RECOMMENDED LDL CHOLESTEROL CONCENTRATIONS WITHATORVASTATIN, FLUVASTATIN, LOVASTATIN, OR SIMVASTATIN IN PATIENTS WITH RISK-FACTORS FOR CORONARY HEART-DISEASE, Journal of family practice, 47(5), 1998, pp. 349-356

Authors: REEVES JR HARRIS F STANTON PD GOING JJ COOKE TG BLACK DM
Citation: Jr. Reeves et al., PATIENT SURVIVAL IN SPORADIC BREAST-CANCER BY BRCA1 IMMUNOREACTIVITY IN CRYOSTAT SECTIONS USING ANTIBODIES MS110 AND MS13, Journal of pathology, 184, 1998, pp. 5-5

Authors: PITT B WATERS D BROWN VW MCCORMICK LS WAGNER B SHURZINSKE L VANBOVEN AJ BLACK DM
Citation: B. Pitt et al., RESULTS OF THE ATORVASTATIN VERSUS REVASCULARIZATION TREATMENTS (AVERT) STUDY - AN 18-MONTH STUDY OF AGGRESSIVE LIPID-LOWERING IN PATIENTS WITH STABLE CORONARY-ARTERY DISEASE INDICATED FOR A CATHETER-BASED REVASCULARIZATION (CR), Circulation, 98(17), 1998, pp. 3342-3342

Authors: KEITH WN ZHAO JQ HOARE SF MCFARLANE R MUIR S PARKINSON K BLACK DM
Citation: Wn. Keith et al., CLONING AND CHARACTERIZATION OF HUMAN AND MOUSE TELOMERASE RNA GENE PROMOTER SEQUENCES, British Journal of Cancer, 78, 1998, pp. 62-62

Authors: BLACK DM THOMPSON DE BAUER D HOCHBERG M ENSTUD K MUSLINER TA YATES AJ CUMMINGS SR
Citation: Dm. Black et al., ANTIFRACTURE EFFICACY OF ALENDRONATE IN PATIENTS AT HIGH-RISK OF FRACTURE - RESULTS FROM THE FRACTURE INTERVENTION TRIAL, Arthritis and rheumatism, 41(9), 1998, pp. 577-577

Authors: ENSRUD K THOMPSON D NEVITT M HOCHBERG M SANTORA A BLACK DM
Citation: K. Ensrud et al., PREVALENT VERTEBRAL FRACTURES PREDICT HOSPITALIZATION AND MORTALITY IN OLDER WOMEN - THE FRACTURE INTERVENTION TRIAL (FIT), Arthritis and rheumatism, 41(9), 1998, pp. 1634-1634

Authors: BLACK DM BAKKERARKEMA RG NAWROCKI JW
Citation: Dm. Black et al., AN OVERVIEW OF THE CLINICAL SAFETY PROFILE OF ATORVASTATIN (LIPITOR),A NEW HMG-COA REDUCTASE INHIBITOR, Archives of internal medicine, 158(6), 1998, pp. 577-584

Authors: MCKENNEY JM MCCORMICK LS WEISS S KOREN M KAFONEK S BLACK DM
Citation: Jm. Mckenney et al., A RANDOMIZED TRIAL OF THE EFFECTS OF ATORVASTATIN AND NIACIN IN PATIENTS WITH COMBINED HYPERLIPIDEMIA OR ISOLATED HYPERTRIGLYCERIDEMIA, The American journal of medicine, 104(2), 1998, pp. 137-143

Authors: BLACK DM
Citation: Dm. Black, EFFICACY AND SAFETY IN PHASE-II TRIALS, The American journal of cardiology, 81(8A), 1998, pp. 25-26

Authors: BLACK DM ORLOFF DG BILHEIMER DW SHEPHERD J OLSSON AG SACKS FM PAOLETTI R CATAPANO A
Citation: Dm. Black et al., SECTION III - SHOULD SEPARATE END-POINT TRIALS BE REQUIRED FOR ALL LIPID-LOWERING DRUGS ACTING BY THE SAME MECHANISM - SECTION III DISCUSSION, The American journal of cardiology, 81(8A), 1998, pp. 92-94

Authors: HERRINGTON DM FONG J SEMPOS CT BLACK DM SCHROTT HG RAUTAHARJU P BACHORIK PS BLUMENTHAL R KHAN S WENGER NK
Citation: Dm. Herrington et al., COMPARISON OF THE HEART AND ESTROGEN PROGESTIN REPLACEMENT STUDY (HERS) COHORT WITH WOMEN WITH CORONARY-DISEASE FROM THE NATIONAL-HEALTH AND NUTRITION EXAMINATION SURVEY III (NHANES-III)/, The American heart journal, 136(1), 1998, pp. 115-124

Authors: SMITH DG BAKKERARMEMA RG MCLAIN RW KOREN MJ BLACK DM
Citation: Dg. Smith et al., THE COMPARATIVE EFFECTS OF ATORVASTATIN IN ACHIEVING DESIRED LIPID-LEVELS FOLLOWING NCEP GUIDELINES, American journal of managed care, 3(10), 1997, pp. 8-8

Authors: SMITH DG BAKKERARKMEMA RG MCLAIN RW BLACK DM
Citation: Dg. Smith et al., THE USE OF ADD-ON TREATMENT IN HMG-COA REDUCTASE INHIBITOR THERAPY TOACHIEVE TARGET LIPID-LEVELS, American journal of managed care, 3(10), 1997, pp. 9-9

Authors: SMITH DG BAKKERARKEMA RG MCLAIN RW BLACK DM
Citation: Dg. Smith et al., VARIATIONS IN COSTS AMONG PAYERS IN TREATMENT WITH HMG-COA REDUCTASE INHIBITOR THERAPY TO ACHIEVE TARGET LIPID-LEVELS, American journal of managed care, 3(10), 1997, pp. 10-10

Authors: OOI TC HEINONEN T ALAUPOVIC P DAVIGNON J LEITER L LUPIEN PJ SNIDERMAN AD TAN MH TREMBLAY G SORISKY A SHURZINSKE L BLACK DM
Citation: Tc. Ooi et al., EFFICACY AND SAFETY OF A NEW HYDROXYMETHYLGLUTARYL-COENZYME A REDUCTASE INHIBITOR, ATORVASTATIN, IN PATIENTS WITH COMBINED HYPERLIPIDEMIA -COMPARISON WITH FENOFIBRATE, Arteriosclerosis, thrombosis, and vascular biology, 17(9), 1997, pp. 1793-1799
Risultati: 1-25 | 26-50 | 51-75 | 76-100 | >>